| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-05 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |